Evidence map›Paper›PMID 36568834›Full record

SynthesisThe Yale journal of biology and medicine2022

The Status of Carbapenem Resistance in Cystic Fibrosis: A Systematic Review and Meta-Analysis.

Mohamed J Saadh, Armaghan Lohrasbi, Elaheh Ghasemian, Marzieh Hashemian, Anahita Etemad, Zahra Dargahi, Vahab Hassan Kaviar

Open access · greenAbstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC
In one paragraph

Synthesis in The Yale journal of biology and medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Mohamed J SaadhFaculty of Pharmacy, Middle East University, Amman, Jordan.
Armaghan LohrasbiDepartment of Biological and Biomedical Sciences, Glasgow Caledonian University, Glasgow, Scotland.
Elaheh GhasemianDepartment of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Tehran, Iran.
Marzieh HashemianClinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Anahita EtemadClinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Zahra DargahiDepartment of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Vahab Hassan KaviarClinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Medical University of Ilam · IRAhvaz Jundishapur University of Medical Sciences · IRApplied Science Private University · JOGlasgow Caledonian University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CarbapenemsCystic FibrosisAnti-Bacterial AgentsDoripenemHumansImipenemMeropenemMicrobial Sensitivity TestsPseudomonas aeruginosaAnti-Bacterial AgentsCarbapenemsDoripenemImipenemMeropenemantimicrobial resistancebacterial pathogenscarbapenem resistancecystic fibrosissystematic review and meta-analysis

Identifiers

PMID36568834
PMCPMC9765336
OpenAlexW4312210760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.